Navigation Links
Arthritis in Dogs is Now Treatable with a Newly-Released High Quality Supplement from Pear & Berry
Date:8/23/2013

WILMINGTON, Del., Aug. 23, 2013 /PRNewswire-iReach/ -- Pear & Berry, a company that specializes in producing top-quality supplements for dogs with hip and joint issues, has just announced the release of an innovative new product that provides the answer to a common question dog owners often have: how to naturally and safely treat arthritis in dogs.

(Photo: http://photos.prnewswire.com/prnh/20130823/MN68652)

As anybody who has had a dog with hip dysplasia or arthritis knows quite well, it can be devastating to watch a beloved family pet have a hard time getting around. While medication and surgery can often help, they are also very costly solutions that many dog owners simply cannot afford. In addition, the pain medications that are typically used to treat dogs with hip dysplasia and arthritis often have dangerous side effects, including chronic liver and kidney problems.

This is where a high quality, all-natural supplement like P&B Hip and Joint Support can help. P&B Hip and Joint Support was specially formulated by a biochemist who has over 28 years of experience studying and working on the complex relationships that exist between natural ingredients and their ability to help with pain relief and joint health.

Through its combination of glucosamine for dogs, chondroitin, MSM and vitamin C—all of which have at least two decades of research behind them—many dogs are able to grow and rebuild their damaged and torn cartilage, which helps them to feel much better. In addition, P&B Hip and Joint Support carries an NASC label, which means it has achieved the highest quality standards in the industry.

"Veterinarians trust glucosamine and chondroitin to prevent the erosion of joints and even reverse years of damage to the tissues that protect your dog's joints," an article on the company's website noted, adding
'/>"/>

SOURCE Pear & Berry
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Flexions Lead Osteoarthritis Drug Candidate Demonstrates Significant, Prolonged Improvement in Pain and Function in Phase 2 Trial
2. Lilly and Incytes Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis
3. Innovations for Osteoarthritis, Sports Injuries and Orthopedic Practices
4. Arthritis Associates of South Florida Acquires Access to Patient Health History Faster with Digital Pen Technology from Anoto and NextGen Healthcare
5. United States Market for Psoriatic Arthritis Pharmacotherapy
6. TSI Healthcare adds Arthritis and Rheumatology Associates of Palm Beach to growing list of Rheumatology Clients
7. Rheumatoid Arthritis New Major Clinical Target After Mesoblast Obtains Positive Results in Inflammatory Arthritis
8. Janssen Announces Initiation Of Phase 3 Development Program For Sirukumab In Rheumatoid Arthritis
9. Protalex, Inc. Announces Screening Of First Patients In U.S. For New Trial Of PRTX-100 In Patients With Active Rheumatoid Arthritis
10. Phase 3 Data Show Intravenous Golimumab Inhibited Radiographic Progression in Patients with Active Rheumatoid Arthritis
11. Epidemiology: Rheumatoid Arthritis in China - Rapid urbanization presents favorable market potential
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... CORAL SPRINGS, Florida , August 3, ... and development agreements between biotech companies, military ... biotech solutions & therapies with regards to ... to positive clinical enhancements for regenerative medicine ... with recent developments, partnerships and advancements in ...
(Date:8/3/2015)... -- Biosensors International Group, Ltd. ("Biosensors" or the ... a developer, manufacturer and marketer of innovative medical ... fiscal quarter ended 30 June 2015 ("Q1 FY16"). ... , Biosensors continued to make ... by lower operating expenses and operational improvement. Operating ...
(Date:8/3/2015)... -- Array BioPharma Inc. (NASDAQ: ARRY ) today ... year of its fiscal year ended June 30, ... Array, noted, "Binimetinib and encorafenib, two innovative oncology ... regulatory submissions in 2016. Additional data shared over ... cancer further validate the value of these programs ...
Breaking Medicine Technology:Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 2Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 3Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 4Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 5Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 6Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 2Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 3Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 4Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 5Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 6Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 2Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 3Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 4Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 5Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 6Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 7Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 8Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 9Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 10Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 11Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 12
... ATLANTA, Dec. 6, 2010 GeoVax Labs, Inc. (OTC Bulletin ... company developing human vaccines for HIV/AIDS (HIV-1, Human Immunodeficiency Virus), ... of Directors effective January 1, 2011. Donald G. Hildebrand is ... as a Director and continue to serve as a consultant ...
... Obesity Society (TOS) and the Obesity Action Coalition (OAC) today ... the urgent need for more tools to address the obesity ... an advisory panel to review a new treatment for obesity. ... Advisory will review a New Drug Application for Contrave, for ...
Cached Medicine Technology:David A. Dodd Appointed Chairman of the Board of GeoVax Labs 2David A. Dodd Appointed Chairman of the Board of GeoVax Labs 3David A. Dodd Appointed Chairman of the Board of GeoVax Labs 4Obesity Organizations Call for a Full and Fair Hearing When the FDA Reviews New Treatments for Obesity 2
(Date:8/3/2015)... ... August 03, 2015 , ... Catalent Pharma Solutions, the ... and consumer health products, today welcomed the announcement by OPKO Health that the ... for a new treatment for chronic kidney disease (CKD) and vitamin D insufficiency, ...
(Date:8/3/2015)... ... August 03, 2015 , ... Novatus, Inc. today launched ... solution, as well as announced the date of its next major release. , ... contract management tasks as well as enhancements to the customer experience. Users ...
(Date:8/3/2015)... ... August 03, 2015 , ... Sensato and ... “Designing Secure Healthcare Systems” This three-day, highly interactive and immersive workshop, has ... with access to the tactics, techniques and practices required to design and develop ...
(Date:8/3/2015)... CA (PRWEB) , ... August 03, 2015 , ... A ... Pain: Injection of Stem Cells Found to Release Natural Painkiller That Can Last 'For ... in patients. According to the report, the new study showed that harvesting stem cell-rich ...
(Date:8/3/2015)... CA (PRWEB) , ... August 03, 2015 , ... ... global insurance brokerage firm, announced today that Joe Williams has joined its growing ... sales, and delivering HUB's differentiated service model to his clients. Mr. Williams will ...
Breaking Medicine News(10 mins):Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 2Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 3Health News:Novatus Unveils Milestone Software Release 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 3Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 4Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2
... Following the,successful OCEANE bond issue, completed last Friday, ... Quantel signed on September 18th a,definitive agreement with ... GmbH, its subsidiary specialized in,dermatology-aesthetics lasers. Conditions ... a EUR4.6 million fixed portion and a,variable portion ...
... Sept. 19 If you,ve been experiencing watery,eyes and ... the,rise in the U.S., with an estimated 50 million ... to the tune of 3 billion,dollars a year, often ... say in-vitro blood tests, the latest generation of,allergy tests, ...
... for diseases such as diabetes and Alzheimer,s , WEDNESDAY, Sept. ... adult stem cells from the testes of male mice into ... contractile cardiac tissue, and brain cells. , If the same ... they may offer a source of new therapies to treat ...
... 20, 2007) -- Easily accessed and plentiful, adult stem cells ... to create a wide range of tissue types to help ... controversial embryonic stem cells. , That,s the promise of a ... Cornell Medical College in New York City, who report their ...
... access to high-quality, evidence-based care for behavioral health,conditions ... The,"Mental Health Parity Act of 2007" would require ... parity with respect to all financial,requirements and all ... "AHIP applauds the Senate for coming together ...
... When Michael Murphy of,Seymour, Iowa, was handed the ... of the September 15th Iowa vs. Iowa State,football game, ... Ride, Iowa",raffle. The Iowa Farm Bureau donated all proceeds ... (tickets were $10 each) to the American,Lung Association of ...
Cached Medicine News:Health News:QUANTEL Finalizes the Acquisition of WaveLight Aesthetic GmbH 2Health News:Stem Cells From Testes Produce Wide Range of Tissue Types 2Health News:Stem cells in adult testes provide alternative to embryonic stem cells for organ regeneration 2Health News:Stem cells in adult testes provide alternative to embryonic stem cells for organ regeneration 3Health News:Stem cells in adult testes provide alternative to embryonic stem cells for organ regeneration 4Health News:Renewable Fuel Chopper Raffle Nets $113,000 for American Lung Association Clean Air Choice Program 2
Uvex Patriot Frame...
... are designed with the safety and comfort of ... RS-520 (also called SF-6) leaded glass, the industry ... standards, as set for optical clarity, visible light ... eyewear is protecting your eyes, it also helps ...
... Goggles fit over glasses ... by the whole department! ... 1.0 mm leaded glass ... scatter radiation protection. Clear ...
Qualcraft™ Radiation Protection Eyewear, Metal, Bifocal. Provides maximum comfort and eye protection! Plano (nonprescription). Black with bronze temple bar....
Medicine Products: